Patrick Terry Email & Phone Number

Denver, Colorado, United States

Full Services Design-Build Company. Engineering. 3D Digital Twin.

Haifa, Haifa District, Israel

Infectious Disease R&D. Medtech

Haifa, Israel

Established a personalized medicine infectious disease biotechnology startup company based on technology created in Israel that creates rapidly developing and commercializing revolutionary solutions to infectious diseases with antibiotic resistance. Secured tens of millions of investment capital and DoD funds for the startup. Guide, mentor, and support a growing international management team. Continue to serve as a Board Member and Business Advisor. • Co-designed an innovative blood test that allows for a better diagnosis of infection, thereby ensuring prescribed medications are better targeted to the body.• Achieved recognition by the World Health Organization (WHO) for pioneering solutions that will impact 10,000 to one million lives after regulatory approval. • Scaled the organization from a startup to a private company now valued at over $1B and tracking towards an IPO, provide ongoing support to the company’s go-to-market journey.

Denver County, Colorado, United States

Consulting. New Venture Business Development. (North America, UK, Europe, Asia)

United States

Fundraising. Corporate Growth. Strategic Partnering. Business Development. Heath System Deployment.

Boulder, Co

** Company NASDAQ SPAC ** Recruited to advance the key initiatives of this private proteomics research and development company. • Built and mentored a 20-member team into a highly adaptive, cohesive, and innovative commercial group.• Played an integral role in securing pharmaceutical partner funding. • Secured a novel strategic partnership for international market creation.

Cambridge, United Kingdom / Raleigh, Nc

** Company Acquired ** Co-founded a new personalized medicine biotechnology startup out of Cambridge University in the UK and secured needed risk capital funding and investor buy-in to enable the company’s successful launch in the U.S. • Successfully created a U.S. subsidiary to help commercialize the company’s cutting-edge technology around the world in just four years. • Played an active role in helping the company rapidly develop and commercialize revolutionary blood-based solutions for various cancer states, thereby replacing outdated tissue biopsies as the new standard for cancer detection in many types of cancers. • Played a critical role in consolidating and boosting the availability of genetic technology to millions of people.

Paris, France / Bethesda, Maryland

** Therapy in Clinical Use Today ** Created functioning multi-stakeholder coalition of multiple different industries to create a business enterprise, policy, and legislation to support the personalized medicine industry, coalitions that remain influential today

Washington Dc

** Company Acquired ** Advised 85+ multi-national client organizations in applied science commercialization fields. • Facilitated transition activities following the acquisition of the company by Scientia Advisors in 2010. • Created a center-of-excellence for precision medicine management advisory group.• Managed expanded diverse client base to permit Scientia to be acquired by a larger firm.

www.PersonalizedMedicineCoalition.orgCreated functioning multi-stakeholder coalition of multiple different industries to create a business enterprise, policy, and legislation to support the personalized medicine industry, coalitions that remain influential today.

Redwood City, Ca

** IPO. Company Acquired $2.8B ** Created a new biotechnology company to drive precision medicine in better supporting patients living with cancer. Secured $154M in venture capital during a Silicon Valley recession. Leveraged a data-driven and personalized approach to medicine to develop continuously disruptive medical solutions. • Successfully organized 800+ stakeholder groups across the United States into one diverse community focused on transforming personalized medicine approaches and patient experiences. • Enabled numerous changes in precision medicine that previously averaged 15-27 years in just four years.• Educated and trained the cancer community in adopting a new treatment paradigm that has saved millions of individuals from experiencing ineffective cancer treatments to date.• Continuously recognized for developing a new paradigm that enabled critical innovation in the delivery of personalized medicine in cancer care.

Bachelor Of Science - Bs, Biomedical/Medical Engineering, 3.5

Bachelor'S Degree, Biotechnology

Associate'S Degree, Biology, General

Education record